[HTML][HTML] Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults

M Sedegah, C Tamminga, S McGrath, B House… - PloS one, 2011 - journals.plos.org
Background Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …

[PDF][PDF] Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1

M Sedegah, C Tamminga, S McGrath, B House… - Part A, 2011 - core.ac.uk
Background: Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …

[PDF][PDF] Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1

M Sedegah, C Tamminga, S McGrath, B House… - Part …, 2011 - pdfs.semanticscholar.org
Background: Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …

[引用][C] Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults

M Sedegah, C Tamminga, S McGrath, B House… - PLoS ONE, 2011 - cir.nii.ac.jp
Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety
and Immunogenicity in Seronegative Adults | CiNii Research CiNii 国立情報学研究所 学術 …

Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults.

M Sedegah, C Tamminga, S McGrath, B House… - Plos one, 2011 - europepmc.org
Background Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …

Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: Safety and immunogenicity in seronegative adults.

M Sedegah, C Tamminga, S McGrath, B House… - PLoS ONE, 2011 - cabdirect.org
Background: Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …

[引用][C] Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults

M Sedegah, C Tamminga, S McGrath, B House… - PLoS …, 2011 - ui.adsabs.harvard.edu
Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and
Immunogenicity in Seronegative Adults - NASA/ADS Now on home page ads icon ads Enable …

Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: Safety and immunogenicity in seronegative adults.

M Sedegah, C Tamminga, S McGrath, B House… - 2011 - cabidigitallibrary.org
Background: Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …

[PDF][PDF] Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1

M Sedegah, C Tamminga, S McGrath, B House… - Part A, 2011 - academia.edu
Background: Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …

Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults

M Sedegah, C Tamminga, S McGrath, B House… - PLoS ONE, 2011 - go.gale.com
Background Models of immunity to malaria indicate the importance of CD8+ T cell
responses for targeting intrahepatic stages and antibodies for targeting sporozoite and …